Search Results - "Vanderstraeten, E"

Evaluation of the safety and effectiveness after switch from adalimumab originator to biosimilar SB5 in patients with inflammatory bowel disease in a real-life setting by Deprez, N, De Somer, T, Baert, D, Deceuninck, M, Huys, I, Mattens, V, Sterckx, A, Vanderstraeten, E, Vandervoort, J, Van Heddegem, N, Dewint, P

“…Prospective data are lacking on evolution of trough levels, effectiveness, acceptance rate and patient satisfaction after switch from the adalimumab originator…”
Get more information

Retrospective observational study on the incidence of incisional hernias after reversal of a temporary diverting ileostomy following rectal carcinoma resection with follow-up CT scans by De Keersmaecker, G., Beckers, R., Heindryckx, E., Kyle-Leinhase, I., Pletinckx, P., Claeys, D., Vanderstraeten, E., Monsaert, E., Muysoms, F.

“…Background Wounds resulting from the closure of temporary stomas have a high risk of developing an incisional hernia (IH) with incidences around 30 % in…”
Get full text

Final results of a phase II quality of life (QOL) randomized, cross-over (CO) study with gemcitabine (Gem) and nab-paclitaxel (n-P) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): QOLINPAC by Chiritescu, G., Dumon, K., Verslype, C., Houbiers, G., Peeters, M., Janssens, J., van Daele, D., Laurent, S., Arts, J., Hendrickx, K., Borbath, I., Ferrante, M., Bastin, F.M., Goeminne, J.-C., van Laethem, J.-L., Vanderstraeten, E., Decaestecker, J., van Vaerenbergh, W., Delhougne, B., Van Cutsem, E.

Get full text

A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results by Chiritescu, G., Dumon, K., Mercadé, T. Macarulla, Lang, I., Vivas, C. Santos, Papai, Z., Janssens, J., Hendrickx, K., Pracht, M., Van den Eynde, M., Taïeb, J., Moons, V., Geboes, K., Van Laethem, J., Greil, R., Cervantes, A., Vergauwe, P., Ferrante, M., Vanderstraeten, E., Fridrik, M., Wöll, E., Limón, M., Rivera, F., Sagaert, X., Tejpar, S., Van Cutsem, E.

Get full text

Gemcitabine with nab-paclitaxel in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): A quality of life randomized cross-over study (QOLINPAC) by Chiritescu, G., Dumon, K., Verslype, C., Prenen, H., Houbiers, G., Peeters, M., Janssens, J., Van Daele, D., Laurent, S., Arts, J., Hendrickx, K., Borbath, I., Ferrante, M., Bastin, F., Goeminne, J., Van Laethem, J., Vanderstraeten, E., Decaestecker, J., Van Vaerenbergh, W., Delhougne, B., Van Cutsem, E.

Get full text

Ischaemic necrosis of the tongue as a rare complication of cardiogenic shock by Hulstaert, E., Roggeman, E., Beeckman, A.-S., Moerman, M., Vanderstraeten, E., Rasquin, K., Monsaert, E., Baert, D., Dewint, P., Burvenich, P., Van Steenkiste, C.

“…Ischaemic necrosis of the tongue is an unusual clinical finding. In most cases it is associated with vasculitis, particularly giant cell arteritis (GCA). Other…”
Get full text

Ischaemic necrosis of the tongue as a rare complication of cardiogenic shock by Hulstaert, E, Roggeman, E, Beeckman, A-S, Moerman, M, Vanderstraeten, E, Rasquin, K, Monsaert, E, Baert, D, Dewint, P, Burvenich, P, Van Steenkiste, C

“…Ischaemic necrosis of the tongue is an unusual clinical finding. In most cases it is associated with vasculitis, particularly giant cell arteritis (GCA). Other…”
Get full text

Intermittent adult ileocecal intussusception: a case report and review of literature by de Clerck, F, Pletinckx, P, Claeys, D, Muysoms, F, Vergucht, V, Burvenich, P, Vanderstraeten, E, Baert, D, Monsaert, E, Rasquin, K, De Cock, G, Van Steenkiste, C

“…We report the case of a 56-year-old male patient who was admitted to the emergency department with crescendo abdominal pain since 2 weeks. In the past 2 years,…”
Get full text

Synthesis of 6-aryl-2,4-diamino-pyrimidines and triazines using palladium catalysed Suzuki cross-coupling reactions by Cooke, Graeme, Augier de Cremiers, Hugues, Rotello, Vincent M, Tarbit, Brian, Vanderstraeten, Petra E

“…The high yielding synthesis of 6-aryl-2,4-diaminopyrimidines and triazines via palladium catalysed Suzuki cross-coupling reactions of commercially available…”
Get full text

CHRONIC DIARRHOEA IN NON COLLAGENOUS MICROSCOPIC COLITIS : THERAPEUTIC EFFECT OF CHOLESTYRAMINE by Baert, D., Coppens, M., Burvenich, P., De Cock, G., Lagae, J., Rasquin, K., Vanderstraeten, E.

“…Chronic watery diarrhoea is the main symptom of the microscopic colitis syndrome, including collagenous colitis (CC), lymphocytic colitis (LC), and not…”
Get full text

EVALUATION OF THE STRATUS® CS FLUOROMETER FOR THE DETERMINATION OF PLASMA MYOGLOBIN by Couck, P., Claeys, R., Vanderstraeten, E., Gorus, F.K.

“…Circulating myoglobin is recognized as an early and sensitive marker of acute coronary diseases. Long turnaround time of myoglobin assays jeopardize their…”
Get full text

Serum gastrin levels and colorectal neoplasia by Elewaut, A, Vanderstraeten, E

Get more information

P396 Acceptance of switch, patient satisfaction and adverse events after switch from adalimumab originator to biosimilar SB5 in patients with Inflammatory Bowel Disease in a real-life setting by De Somer, T, Deprez, N, Baert, D, Deceuninck, M, Huys, I, Mattens, V, Sterckx, A, Vanden Branden, S, Vanderstraeten, E, Vandervoort, J, Van Heddegem, N, Dewint, P

“…Abstract Background SB5 is approved as a biosimilar of the adalimumab originator. However, data on patient acceptance of switch from originator to biosimilar,…”
Get full text

P281 Evaluation of trough level and disease activity after switch from adalimumab originator to biosimilar in patients with Inflammatory Bowel Disease by Deprez, N, De Somer, T, Baert, D, Deceuninck, M, Huys, I, Mattens, V, Sterckx, A, Vanden Branden, S, Vanderstraeten, E, Vandervoort, J, Vanheddegem, N, Dewint, P

“…Abstract Background SB5 is approved as a biosimilar to the adalimumab (ADA) originator. Bio- and efficacy equivalence, as well as comparable safety and…”
Get full text

Serum gastrin levels and colorectal neoplasia by Vanderstraeten, E F, De Vos, M M, Versieck, J M, Elewaut, A P

“…Confirmation of an association between elevated serum gastrin concentrations and presence of colorectal tumors would have important implications with regard to…”
Get more information

740PFinal results of a phase II quality of life (QOL) randomized, cross-over (CO) study with gemcitabine (Gem) and nab-paclitaxel (n-P) in locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): QOLINPAC by Chiritescu, G, Dumon, K, Verslype, C, Houbiers, G, Peeters, M, Janssens, J, van Daele, D, Laurent, S, Arts, J, Hendrickx, K, Borbath, I, Ferrante, M, Bastin, F M, Goeminne, J-C, van Laethem, J-L, Vanderstraeten, E, Decaestecker, J, van Vaerenbergh, W, Delhougne, B, Van Cutsem, E

Get full text

O-015A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results by Chiritescu, G, Dumon, K, Mercadé, T Macarulla, Lang, I, Vivas, C Santos, Papai, Z, Janssens, J, Hendrickx, K, Pracht, M, Van den Eynde, M, Taïeb, J, Moons, V, Geboes, K, Van Laethem, J, Greil, R, Cervantes, A, Vergauwe, P, Ferrante, M, Vanderstraeten, E, Fridrik, M, Wöll, E, Limón, M, Rivera, F, Sagaert, X, Tejpar, S, Van Cutsem, E

Get full text

O-003Gemcitabine with nab-paclitaxel in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): A quality of life randomized cross-over study (QOLINPAC) by Chiritescu, G, Dumon, K, Verslype, C, Prenen, H, Houbiers, G, Peeters, M, Janssens, J, Van Daele, D, Laurent, S, Arts, J, Hendrickx, K, Borbath, I, Ferrante, M, Bastin, F, Goeminne, J, Van Laethem, J, Vanderstraeten, E, Decaestecker, J, Van Vaerenbergh, W, Delhougne, B, Van Cutsem, E

Get full text

Adult intussusception: 10-year experience in two Belgian centres by de Clerck, F, Vanderstraeten, E, De Vos, M, Van Steenkiste, C

“…adult intussusception is a rare entity with a different clinical presentation and aetiology than in children. Objective: To provide a comprehensive overview of…”
Get more information

Weekly Versus Biweekly Combination of Docetaxel (D)-Cisplatin (C)-5Fu (F) in Advanced Gastric Cancer and Esogastric Junction Adenocarcinoma (Agc): Doge Study by Deleporte, A., Eynde, M. van den, Forget, F., Holbrechts, S., Delaunoit, T., Houbiers, G., Kalantari, H. Rezaei, Laurent, S., Vanderstraeten, E., De Man, M., Vergauwe, P., Clausse, M., Vanderauwera, J., Pierre, P., D'Hondt, L., Ghillemijn, B., Covas, A., Paesmans, M., Ameye, L., Hendlisz, A.

Get full text